|
VAERS ID: |
566066 (history) |
Form: |
Version 1.0 |
Age: |
|
Sex: |
Female |
Location: |
Unknown |
Vaccinated: | 2015-01-17 |
Onset: | 0000-00-00 |
Submitted: |
2015-01-27 |
Entered: |
2015-01-27 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. |
- / UNK |
UN / SC |
Administered by: Other Purchased by: Other Symptoms: Breast feeding,
No adverse event SMQs:
Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: Other Medications: No other medications Current Illness: Unknown Preexisting Conditions: Allergies: Diagnostic Lab Data: CDC Split Type: WAES1501USA010196
Write-up: This spontaneous report as received from a medical assistant refers to a female patient of unknown age. On 17-JAN-2015 (reported as about 1 week ago) the patient was vaccinated with M-M-R II, 0.5 ml, subcutaneous. Concomitant medication was not reported. The patient who was breastfeeding was administered with M-M-R II. No adverse effects reported. The outcome of the event was unknown. The reporter considered the event to be not related to M-M-R II. Additional information is not expected. |
|
VAERS ID: |
703512 (history) |
Form: |
Version 2.0 |
Age: |
0.0 |
Sex: |
Female |
Location: |
Michigan |
Vaccinated: | 2017-05-24 |
Onset: | 2017-05-26 |
Days after vaccination: | 2 |
Submitted: |
0000-00-00 |
Entered: |
2017-07-12 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. |
N002922 / 1 |
LL / IM |
Administered by: Private Purchased by: ? Symptoms: Breast feeding,
Cardiac arrest,
Cyanosis,
Hypotonia,
Intensive care,
Laboratory test,
Nervous system disorder,
Respiratory arrest SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (narrow), Peripheral neuropathy (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypersensitivity (broad), Respiratory failure (narrow), Noninfectious myocarditis/pericarditis (broad)
Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 52 days
Extended hospital stay? No Previous Vaccinations: Other Medications: vitamin D infant drops Current Illness: none Preexisting Conditions: none Allergies: none Diagnostic Lab Data: Tests were all preformed at Hospital 5/26/17 CDC Split Type:
Write-up: Patient had gone into cardiac arrest two days later, mom was breastfeeding and baby went blue and stopped breathing, treated in intensive care unit for over 1 month, outcome with poor tone with neurological impairment. |
|
VAERS ID: |
886793 (history) |
Form: |
Version 2.0 |
Age: |
0.17 |
Sex: |
Male |
Location: |
Virginia |
Vaccinated: | 2020-07-23 |
Onset: | 2020-07-23 |
Days after vaccination: | 0 |
Submitted: |
0000-00-00 |
Entered: |
2020-09-30 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS |
- / 1 |
MO / PO |
Administered by: Military Purchased by: ? Symptoms: Breast feeding,
Diarrhoea,
Diet refusal,
Pain,
Screaming SMQs:, Pseudomembranous colitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Noninfectious diarrhoea (narrow)
Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: Other Medications: Vitamin D, infant tylenol Current Illness: None Preexisting Conditions: None Allergies: Unknown Diagnostic Lab Data: CDC Split Type:
Write-up: Screaming in pain for multiple hours straight for several days after, refusing to breastfeed for almost 7 hours, diarrhea for more than 10 days |
|
VAERS ID: |
1000876 (history) |
Form: |
Version 2.0 |
Age: |
30.0 |
Sex: |
Female |
Location: |
North Carolina |
Vaccinated: | 2017-08-21 |
Onset: | 2017-09-08 |
Days after vaccination: | 18 |
Submitted: |
0000-00-00 |
Entered: |
2021-02-04 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. |
N002337 / 3 |
RA / SC |
Administered by: Private Purchased by: ? Symptoms: Antinuclear antibody negative,
Arthralgia,
Blood uric acid normal,
Breast feeding,
Differential white blood cell count normal,
Fatigue,
Full blood count normal,
Glomerular filtration rate normal,
Joint stiffness,
Loss of personal independence in daily activities,
Metabolic function test normal,
Red blood cell sedimentation rate normal,
Rheumatoid factor negative,
X-ray limb normal SMQs:, Dementia (broad), Arthritis (broad), Tendinopathies and ligament disorders (broad)
Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: Other Medications: Hydromorphone 2mg, Colace stool softener 50mg, Iron 27mg Current Illness: C-section performed 8/18/2017 - recovering from surgery Preexisting Conditions: n/a Allergies: none Diagnostic Lab Data: X-rays (writs, hands, knees) and blood work (glomerular filtration rate estimate, CMP, uric acid, sed rate, rheumatoid factor, cbc, with differential, aniti ab ana reflex cascade). All tests came back within normal limits. CDC Split Type:
Write-up: Patient began having joint stiffness and pain 3 weeks following vaccination. By ~6 weeks following vaccination, stiffness and pain escalated to the point that she struggles to perform daily tasks. (Hold a pencil, get in and out of a chair, go up and down stairs, put on daughter''s clothing, etc.) Primary joints affected were hands (predominantly right), ankles, and knees. Occasional pain through wrist. Pain continued for 14 months, flaring more significantly during hormonal changes seemingly relate to breastfeeding. During these periods, patient experienced significant fatigue and was unable to perform daily activities. Chiropractic care, nutritional supplements, and dietary changes with the intent to decrease inflammation had positive impact on severity. Patient continues to need lifestyle measures to manage symptoms. There is no other medical explanation for patient''s symptoms, so this is a probable reaction to MMR |
|
VAERS ID: |
877550 (history) |
Form: |
Version 2.0 |
Age: |
0.17 |
Sex: |
Female |
Location: |
Foreign |
Vaccinated: | 2020-05-01 |
Onset: | 0000-00-00 |
Submitted: |
0000-00-00 |
Entered: |
2020-07-30 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
6VAX-F: DTAP+IPV+HEPB+HIB (NO BRAND NAME) / UNKNOWN MANUFACTURER |
UNKNOWN / UNK |
- / - |
Administered by: Other Purchased by: ? Symptoms: Allergy test negative,
Breast feeding,
Eye swelling,
Rash,
Restlessness,
Urticaria SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Anticholinergic syndrome (broad), Dementia (broad), Akathisia (broad), Noninfectious encephalopathy/delirium (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)
Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 1 days
Extended hospital stay? No Previous Vaccinations: Other Medications: Current Illness: Preexisting Conditions: Allergies: Diagnostic Lab Data: CDC Split Type:
Write-up: |
|
VAERS ID: |
996693 (history) |
Form: |
Version 2.0 |
Age: |
0.08 |
Sex: |
Female |
Location: |
Foreign |
Vaccinated: | 2018-11-20 |
Onset: | 2018-11-20 |
Days after vaccination: | 0 |
Submitted: |
0000-00-00 |
Entered: |
2021-02-03 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
DTP: DTP (NO BRAND NAME) / UNKNOWN MANUFACTURER |
20917002A / UNK |
- / OT |
HEP: HEP B (FOREIGN) / MERCK & CO. INC. |
- / UNK |
- / OT |
HIBV: HIB (ACTHIB) / SANOFI PASTEUR |
- / UNK |
- / OT |
PNC10: PNEUMO (SYNFLORIX) / GLAXOSMITHKLINE BIOLOGICALS |
- / UNK |
- / OT |
Administered by: Other Purchased by: ? Symptoms: Abdominal pain,
Agitation,
Apathy,
Breast feeding,
Constipation,
Crying,
Decreased appetite,
Diarrhoea,
Febrile convulsion,
Hyperaesthesia,
Insomnia,
Muscle strain,
Poor feeding infant,
Product administered to patient of inappropriate age,
Pyrexia,
Somnolence,
Vaccination site erythema,
Vaccination site oedema,
Vaccination site swelling,
Vomiting SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (narrow), Retroperitoneal fibrosis (broad), Dementia (broad), Convulsions (narrow), Pseudomembranous colitis (broad), Psychosis and psychotic disorders (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Depression (excl suicide and self injury) (broad), Neonatal disorders (narrow), Generalised convulsive seizures following immunisation (narrow), Noninfectious diarrhoea (narrow), Tendinopathies and ligament disorders (broad), Medication errors (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)
Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: Other Medications: Current Illness: Preexisting Conditions: Allergies: Diagnostic Lab Data: CDC Split Type:
Write-up: |
|
Vaccinated: | 2018-01-12 |
Onset: | 0000-00-00 |
Submitted: |
0000-00-00 |
Entered: |
2022-06-02 |
Vaccination / Manufacturer |
Lot / Dose |
Site / Route |
TDAP: TDAP (NO BRAND NAME) / UNKNOWN MANUFACTURER |
UNK / UNK |
- / SYR |
UNK: VACCINE NOT SPECIFIED (NO BRAND NAME) / UNKNOWN MANUFACTURER |
UNK / UNK |
- / SYR |
Administered by: Unknown Purchased by: ? Symptoms: Breast feeding,
Foetal exposure during pregnancy SMQs:, Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow)
Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Extended hospital stay? Yes Previous Vaccinations: Other Medications: Current Illness: Preexisting Conditions: Allergies: Diagnostic Lab Data: CDC Split Type: BRGLAXOSMITHKLINEBR2022GS
Write-up: developed other health conditions or complications and was hospitalized because of that; Fetal exposure during pregnancy, second trimester; This retrospective pregnancy case was reported by a other health professional via licensee and described the occurrence of hospitalization in a male infant exposed to DTPa (Reduced antigen) (dTpa vaccine) in utero. The mother received the product for prophylaxis. Co-suspect product exposures included INFLUENZA VIRUS VACCINE INACTIVATED (VAXIGRIP SANOFI (FLU VACCINE)). On 12th January 2018, the mother received dTpa vaccine (intramuscular) and VAXIGRIP SANOFI (FLU VACCINE) (intramuscular). The mother''s last menstrual period was on an unknown date and estimated date of delivery was on an unknown date. The infant was exposed to dTpa vaccine at an unknown time during the pregnancy. The infant was born via unknown delivery. The infant was diagnosed with hospitalization (serious criteria hospitalization) and fetal exposure during pregnancy, second trimester. On an unknown date, the outcome of the hospitalization and fetal exposure during pregnancy, second trimester were unknown. It was unknown if the reporter considered the hospitalization to be related to dTpa vaccine. See case BR2022GSK086821 for details regarding the mother case. Additional Information: GSK Receipt Date: 20-MAY-2022 Reporter''s Comment: The pharmacovigilance document by Sanofi, containing information on a severe adverse event report after using an adsorbent vaccine against diphtheria, tetanus, and (acellular) pertussis (dTpa vaccine). The mother gave birth on male baby 49 cm tall and normal head circumference. The patient survived his first 28 days of life. The baby was on exclusive breastfeeding (no formula) during the hospitalization period, more than once a day. The baby developed other health conditions or complications between his 29th day and 1 year of life, and was hospitalized because of that.; Sender''s Comments: BR-GLAXOSMITHKLINE-BR2022GSK086821:Mother case |
|